MedPath
HSA Approval

PROPOFOL 1% MCT/LCT FRESENIUS EMULSION FOR INJECTION OR INFUSION

SIN11577P

PROPOFOL 1% MCT/LCT FRESENIUS EMULSION FOR INJECTION OR INFUSION

PROPOFOL 1% MCT/LCT FRESENIUS EMULSION FOR INJECTION OR INFUSION

July 4, 2001

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Licence HolderFRESENIUS KABI (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

N01AX10

propofol

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI AUSTRIA GMBH

Active Ingredients

PROPOFOL

1%

Propofol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROPOFOL 1% MCT/LCT FRESENIUS EMULSION FOR INJECTION OR INFUSION - HSA Approval | MedPath